Global Mitral Valve Disease Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250115

Publication Date:

June 17, 2025

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Mitral Valve Disease market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淢itral Valve Disease Industry Forecast鈥� looks at past sales and reviews total world Mitral Valve Disease sales in 2024, providing a comprehensive analysis by region and market sector of projected Mitral Valve Disease sales for 2025 through 2031. With Mitral Valve Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mitral Valve Disease industry.
This Insight Report provides a comprehensive analysis of the global Mitral Valve Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mitral Valve Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Mitral Valve Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mitral Valve Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mitral Valve Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Mitral Valve Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
Mitral Valve Repair
Mitral Valve Replacement
Mitral Valve Therapeutics
Segmentation by Application:
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Zydus Lifesciences Limited
Affluent Medical
Artivion, Inc.
Valcare Medical
Corcym UK Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Medtronic plc
ShockWave Medical, Inc.
Braile Biomedica
Abbott Laboratories
Labcor Laboratorios Ltda
Edwards Lifesciences Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mitral Valve Disease Market Size (2020-2031)
2.1.2 Mitral Valve Disease Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Mitral Valve Disease by Country/Region (2020, 2024 & 2031)
2.2 Mitral Valve Disease Segment by Type
2.2.1 Mitral Valve Repair
2.2.2 Mitral Valve Replacement
2.2.3 Mitral Valve Therapeutics
2.3 Mitral Valve Disease Market Size by Type
2.3.1 Mitral Valve Disease Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Mitral Valve Disease Market Size Market Share by Type (2020-2025)
2.4 Mitral Valve Disease Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Mitral Valve Disease Market Size by Application
2.5.1 Mitral Valve Disease Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Mitral Valve Disease Market Size Market Share by Application (2020-2025)
3 Mitral Valve Disease Market Size by Player
3.1 Mitral Valve Disease Market Size Market Share by Player
3.1.1 Global Mitral Valve Disease Revenue by Player (2020-2025)
3.1.2 Global Mitral Valve Disease Revenue Market Share by Player (2020-2025)
3.2 Global Mitral Valve Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Mitral Valve Disease by Region
4.1 Mitral Valve Disease Market Size by Region (2020-2025)
4.2 Global Mitral Valve Disease Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mitral Valve Disease Market Size Growth (2020-2025)
4.4 APAC Mitral Valve Disease Market Size Growth (2020-2025)
4.5 Europe Mitral Valve Disease Market Size Growth (2020-2025)
4.6 Middle East & Africa Mitral Valve Disease Market Size Growth (2020-2025)
5 Americas
5.1 Americas Mitral Valve Disease Market Size by Country (2020-2025)
5.2 Americas Mitral Valve Disease Market Size by Type (2020-2025)
5.3 Americas Mitral Valve Disease Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mitral Valve Disease Market Size by Region (2020-2025)
6.2 APAC Mitral Valve Disease Market Size by Type (2020-2025)
6.3 APAC Mitral Valve Disease Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Mitral Valve Disease Market Size by Country (2020-2025)
7.2 Europe Mitral Valve Disease Market Size by Type (2020-2025)
7.3 Europe Mitral Valve Disease Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mitral Valve Disease by Region (2020-2025)
8.2 Middle East & Africa Mitral Valve Disease Market Size by Type (2020-2025)
8.3 Middle East & Africa Mitral Valve Disease Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Mitral Valve Disease Market Forecast
10.1 Global Mitral Valve Disease Forecast by Region (2026-2031)
10.1.1 Global Mitral Valve Disease Forecast by Region (2026-2031)
10.1.2 Americas Mitral Valve Disease Forecast
10.1.3 APAC Mitral Valve Disease Forecast
10.1.4 Europe Mitral Valve Disease Forecast
10.1.5 Middle East & Africa Mitral Valve Disease Forecast
10.2 Americas Mitral Valve Disease Forecast by Country (2026-2031)
10.2.1 United States Market Mitral Valve Disease Forecast
10.2.2 Canada Market Mitral Valve Disease Forecast
10.2.3 Mexico Market Mitral Valve Disease Forecast
10.2.4 Brazil Market Mitral Valve Disease Forecast
10.3 APAC Mitral Valve Disease Forecast by Region (2026-2031)
10.3.1 China Mitral Valve Disease Market Forecast
10.3.2 Japan Market Mitral Valve Disease Forecast
10.3.3 Korea Market Mitral Valve Disease Forecast
10.3.4 Southeast Asia Market Mitral Valve Disease Forecast
10.3.5 India Market Mitral Valve Disease Forecast
10.3.6 Australia Market Mitral Valve Disease Forecast
10.4 Europe Mitral Valve Disease Forecast by Country (2026-2031)
10.4.1 Germany Market Mitral Valve Disease Forecast
10.4.2 France Market Mitral Valve Disease Forecast
10.4.3 UK Market Mitral Valve Disease Forecast
10.4.4 Italy Market Mitral Valve Disease Forecast
10.4.5 Russia Market Mitral Valve Disease Forecast
10.5 Middle East & Africa Mitral Valve Disease Forecast by Region (2026-2031)
10.5.1 Egypt Market Mitral Valve Disease Forecast
10.5.2 South Africa Market Mitral Valve Disease Forecast
10.5.3 Israel Market Mitral Valve Disease Forecast
10.5.4 Turkey Market Mitral Valve Disease Forecast
10.6 Global Mitral Valve Disease Forecast by Type (2026-2031)
10.7 Global Mitral Valve Disease Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Mitral Valve Disease Forecast
11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Mitral Valve Disease Product Offered
11.1.3 Bayer AG Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 Zydus Lifesciences Limited
11.2.1 Zydus Lifesciences Limited Company Information
11.2.2 Zydus Lifesciences Limited Mitral Valve Disease Product Offered
11.2.3 Zydus Lifesciences Limited Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Zydus Lifesciences Limited Main Business Overview
11.2.5 Zydus Lifesciences Limited Latest Developments
11.3 Affluent Medical
11.3.1 Affluent Medical Company Information
11.3.2 Affluent Medical Mitral Valve Disease Product Offered
11.3.3 Affluent Medical Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Affluent Medical Main Business Overview
11.3.5 Affluent Medical Latest Developments
11.4 Artivion, Inc.
11.4.1 Artivion, Inc. Company Information
11.4.2 Artivion, Inc. Mitral Valve Disease Product Offered
11.4.3 Artivion, Inc. Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Artivion, Inc. Main Business Overview
11.4.5 Artivion, Inc. Latest Developments
11.5 Valcare Medical
11.5.1 Valcare Medical Company Information
11.5.2 Valcare Medical Mitral Valve Disease Product Offered
11.5.3 Valcare Medical Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Valcare Medical Main Business Overview
11.5.5 Valcare Medical Latest Developments
11.6 Corcym UK Limited
11.6.1 Corcym UK Limited Company Information
11.6.2 Corcym UK Limited Mitral Valve Disease Product Offered
11.6.3 Corcym UK Limited Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Corcym UK Limited Main Business Overview
11.6.5 Corcym UK Limited Latest Developments
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Information
11.7.2 Pfizer Inc. Mitral Valve Disease Product Offered
11.7.3 Pfizer Inc. Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer Inc. Main Business Overview
11.7.5 Pfizer Inc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Mitral Valve Disease Product Offered
11.8.3 Novartis AG Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Information
11.9.2 Teva Pharmaceutical Industries Ltd. Mitral Valve Disease Product Offered
11.9.3 Teva Pharmaceutical Industries Ltd. Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.10 Medtronic plc
11.10.1 Medtronic plc Company Information
11.10.2 Medtronic plc Mitral Valve Disease Product Offered
11.10.3 Medtronic plc Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Medtronic plc Main Business Overview
11.10.5 Medtronic plc Latest Developments
11.11 ShockWave Medical, Inc.
11.11.1 ShockWave Medical, Inc. Company Information
11.11.2 ShockWave Medical, Inc. Mitral Valve Disease Product Offered
11.11.3 ShockWave Medical, Inc. Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ShockWave Medical, Inc. Main Business Overview
11.11.5 ShockWave Medical, Inc. Latest Developments
11.12 Braile Biomedica
11.12.1 Braile Biomedica Company Information
11.12.2 Braile Biomedica Mitral Valve Disease Product Offered
11.12.3 Braile Biomedica Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Braile Biomedica Main Business Overview
11.12.5 Braile Biomedica Latest Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Information
11.13.2 Abbott Laboratories Mitral Valve Disease Product Offered
11.13.3 Abbott Laboratories Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Abbott Laboratories Main Business Overview
11.13.5 Abbott Laboratories Latest Developments
11.14 Labcor Laboratorios Ltda
11.14.1 Labcor Laboratorios Ltda Company Information
11.14.2 Labcor Laboratorios Ltda Mitral Valve Disease Product Offered
11.14.3 Labcor Laboratorios Ltda Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Labcor Laboratorios Ltda Main Business Overview
11.14.5 Labcor Laboratorios Ltda Latest Developments
11.15 Edwards Lifesciences Corporation
11.15.1 Edwards Lifesciences Corporation Company Information
11.15.2 Edwards Lifesciences Corporation Mitral Valve Disease Product Offered
11.15.3 Edwards Lifesciences Corporation Mitral Valve Disease Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Edwards Lifesciences Corporation Main Business Overview
11.15.5 Edwards Lifesciences Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂